Arachne.ai appears to be a legitimate early-stage B2B biotech software provider based on external verification, but the submission itself is severely flawed. The input claims 'most people have used my product' and lists an audience of 'everyone,' which is factually incorrect for a specialized computational drug discovery platform. While the underlying technology concept (data infrastructure for TechBio) addresses a real industry problem, the lack of verifiable traction, the tiny team size (likely ~2 employees), and the nonsensical metrics provided in the submission result in a very low score.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline